As part of an overall effort by the US Congress to stop the ongoing opioid epidemic, a key Senate Committee and House subcommittee approved bills this week to expedite approval of non-addictive devices and drugs that could serve as alternatives to opioids for control of acute and chronic pain.
On April 24, the Senate HELP Committee passed the “Opioid Crisis Response Act of 2018,” onto the full Senate
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?